Seattle CRC LLC

1. Organon LLC $863,272 183 payments
2. Moderna TX, Inc. $550,517 34 payments
3. Mylan Inc. $389,596 30 payments
4. GlaxoSmithKline, LLC. $320,569 47 payments
5. Sebela Women's Health Inc. $178,612 16 payments
6. Sumitomo Pharma America, Inc. $160,870 46 payments
7. Pfizer Inc. $100,691 25 payments
8. Biohaven Pharmaceutical Holding Company Ltd. $71,929 21 payments
9. Exeltis, USA Inc. $37,733 10 payments
10. AbbVie, Inc. $36,936 12 payments

1. Mr-100A-01-Td-3001-A Phase 3, Multicenter, Open-Label, Single Arm Study of Mr-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety $389,596 30 payments
2. A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age $382,517 27 payments
3. Og-8175A-023 $364,091 117 payments
4. Og-8175A-023 $268,283 20 payments
5. A Phase III, Observer-Blind, Randomized, Multi-Country Study to Evalua $190,846 25 payments
6. A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate VeraCept, a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy, Safety, and Tolerability $173,021 11 payments
7. A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ?60 Years of Age $168,000 7 payments
8. A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids Or Endometriosis $105,409 27 payments
9. Og-6219-P001 $60,794 2 payments
10. Efficacy and Safety of Nexplanon 36 to 60 Months Post Insertion $59,772 12 payments

1. Patient care $863,272 183 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.